Development of a highly sensitive quantitative competitive PCR assay for the detection of murine cytomegalovirus DNA.

[1]  S. Jonjić,et al.  Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection , 1998, The Journal of experimental medicine.

[2]  J. Harris,et al.  Latency versus Persistence or Intermittent Recurrences : Evidence for a Latent State of Murine Cytomegalovirus in the Lungs , 1996 .

[3]  Y. Burstein,et al.  Treatment of murine cytomegalovirus salivary-gland infection by combined therapy with ganciclovir and thymic humoral factor gamma 2. , 1996, Antiviral research.

[4]  S. Henry,et al.  Expression of a murine cytomegalovirus early-late protein in "latently" infected mice. , 1995, The Journal of infectious diseases.

[5]  E. Mocarski,et al.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. G. Stevens,et al.  Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. , 1994, Virology.

[7]  L. Steinman,et al.  Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during development and resolution of experimental allergic encephalomyelitis , 1993, Journal of Neuroimmunology.

[8]  C. Pomeroy,et al.  Detection of latent cytomegalovirus DNA in diverse organs of mice. , 1993, The Journal of infectious diseases.

[9]  S. Henry,et al.  Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice. , 1993, The Journal of infectious diseases.

[10]  K. Yee,et al.  Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodeficiency virus. , 1993, Journal of clinical periodontology.

[11]  M. Uhlén,et al.  Human immunodeficiency virus type 1 and cytomegalovirus in saliva , 1993, Journal of medical virology.

[12]  U. Koszinowski,et al.  Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus , 1992, Journal of virology.

[13]  M. Glick,et al.  Intraoral cytomegalovirus lesion and HIV-associated periodontitis in a patient with acquired immunodeficiency syndrome. , 1991, Oral surgery, oral medicine, and oral pathology.

[14]  J. Feinberg,et al.  Current status of HIV therapy: II. Opportunistic diseases. , 1991, Hospital Practice.

[15]  P. Klotman,et al.  Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. , 1990, The Journal of infectious diseases.

[16]  D. Engler,et al.  Allergic rhinitis: a practical approach. , 1990, Hospital practice.

[17]  Y. Burstein,et al.  Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV). , 1987, Clinical and experimental immunology.

[18]  N. Flournoy,et al.  Risk factors for cytomegalovirus infection after human marrow transplantation. , 1986, The Journal of infectious diseases.

[19]  J. G. Stevens,et al.  Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection. , 1982, The Journal of infectious diseases.

[20]  Shanley Jd,et al.  Immunosuppression reactivates and disseminates latent murine cytomegalovirus. , 1977 .

[21]  E. Mocarski,et al.  Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. , 1995, Scandinavian journal of infectious diseases. Supplementum.